| Authors: |
Parsons HA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: hparsons@fredhutch.org., Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Santos K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA., Weiss J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Merrell D; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Danysh BP; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hughes ME; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Yale Cancer Center, New Haven, CT, USA., Kirkner GJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Patel A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sendrick K; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Stewart C; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Grant E; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Schlueter-Kuck K; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Grinshpun A; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wagle N; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Veeraraghavan J; Baylor College of Medicine, Houston, TX, USA., Leone JP; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Freedman RA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Metzger O; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Schiff R; Baylor College of Medicine, Houston, TX, USA., Winer EP; Yale Cancer Center, New Haven, CT, USA., Tolaney SM; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Rimawi M; Baylor College of Medicine, Houston, TX, USA., Krop IE; Yale Cancer Center, New Haven, CT, USA., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA; Massachusetts General Hospital, Boston, MA, USA., Lin NU; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. |
